C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
11/2006
11/16/2006	WO2006122156A2 Compounds for modulating trpv3 function
11/16/2006	WO2006121922A1 Monoamine re-uptake inhibitors and methods relating thereto
11/16/2006	WO2006121097A1 Bicyclic heterocyclic derivative or salt thereof
11/16/2006	WO2006120478A2 Quinoline derivatives as neurokinin receptor antagonists
11/16/2006	WO2006120224A1 Fungicide 2-pyridyl-methylene-carboxamide derivatives
11/16/2006	WO2006120104A1 Inhibitors of prolyl endopeptidase
11/16/2006	WO2006119646A1 Compounds and methods for the treatment or prevention of flavivirus infections
11/16/2006	WO2006086705B1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
11/16/2006	WO2006063860A3 Process for obtaining enantiomers of thienylazolylalcoxyethanamines
11/16/2006	WO2006051397A3 Oligonucleotide probes
11/16/2006	WO2005117882A3 Hydroxamic acid derivatives as metalloprotease inhibitors
11/16/2006	US20060258720 1-Aroyl-2-heteroaryl- or heterocyclyl-4-alkyl-4-pyrrolidinylcarboxylic acids or esters (rel-(2S,4R,5R)-2-Isobutyl-1-(3-methoxy-4-tert-butylbenzoyl)-4-ethoxymethyl-5-(1,3-thiazol-2-yl)pyrrolidine-2-carboxylic acid); antiviral agents; hepatitus C
11/16/2006	US20060258704 2-Oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivatives for the treatment of epilepsy and other neurological disorders
11/16/2006	US20060258678 Novel indole derivatives
11/16/2006	US20060258666 c-fms kinase inhibitors
11/16/2006	US20060258658 Triazole compounds useful as protein kinase inhibitors
11/16/2006	US20060258653 Derivatives of sulphonamides, their preparation and use as medicaments
11/16/2006	US20060258641 Methods and compositions of novel triazine compounds
11/16/2006	CA2608194A1 Compounds for modulating trpv3 function
11/16/2006	CA2607917A1 Fungicide 2-pyridyl-methylene-carboxamide derivatives
11/16/2006	CA2607874A1 Quinoline derivatives as neurokinin receptor antagonists
11/16/2006	CA2607198A1 Dihydroxyphenylalanine derivatives
11/15/2006	EP1721904A1 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
11/15/2006	EP1721609A2 Pyridylpyrimidine derivatives as effective compounds against prion infections and prion diseases
11/15/2006	EP1720866A1 Production method
11/15/2006	EP1720865A1 2-pyridinylethylcarboxamide derivatives and their use as fungicides
11/15/2006	EP1720864A1 Benzimidazol substituted thiophene derivatives with activity on ikk3
11/15/2006	EP1720863A2 Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
11/15/2006	EP1720862A1 Kinase inhibitors
11/15/2006	EP1720859A2 Chemokine receptor antagonists
11/15/2006	EP1720857A1 Dihydropyridinone derivatives
11/15/2006	EP1720855A1 Inhibitors of akt activity
11/15/2006	EP1720843A2 Process for the preparation of substituted triazole compounds
11/15/2006	EP1720839A1 Pyridazinones as antagonists of a4 integrins
11/15/2006	EP1720837A1 Derivatives of n-' (1,5-diphenyl-1h-pyrazol-3-yl) sulphonamide with cb1 receptor affinity
11/15/2006	EP1720836A1 6-substituted 2,3,4,5-tetrahydro-1h-benzo [d]azepines as 5-ht2c receptor agonists
11/15/2006	EP1720553A1 Pyrimidine compounds as purine receptor antagonist
11/15/2006	EP1427718B1 Benzothiepine ileal bile acid transport inhibotors
11/15/2006	EP1411881B9 5ht2c receptor modulators
11/15/2006	EP1401434B1 Modulators of peroxisome proliferator activated receptors (ppar)
11/15/2006	EP0968206B1 N-heterocyclic derivatives as nos inhibitors
11/15/2006	CN1863800A Novel compounds that modulate PPAR type receptors, and use thereof in cosmetic or pharmaceutical compositions
11/15/2006	CN1863798A 2,4-dioxo-3-quinazolinylaryl sulfonylureas
11/15/2006	CN1863795A P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same
11/15/2006	CN1863789A Substituted isoquinolinones
11/15/2006	CN1863780A Protein kinase inhibitors and uses thereof
11/15/2006	CN1863770A Cyclic amine BASE-1 inhibitors having a heterocyclic substituent
11/15/2006	CN1284783C Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase
11/15/2006	CN1284771C TNF－α生成抑制剂 TNF-α production inhibitor
11/14/2006	US7135495 Indole derivatives
11/14/2006	US7135493 HDAC inhibitor
11/14/2006	US7135491 5-Aryltetrazole compounds and uses thereof
11/14/2006	US7135487 Sulphonamide derivatives
11/14/2006	US7135486 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
11/14/2006	US7135484 Azabicyclic compounds are central nervous system active agents
11/14/2006	US7135479 Compounds which are both serotonin reuptake inhibitors and antagonists of the 5HT1A receptor
11/14/2006	US7135473 Cyclic diamine compound with condensed-ring groups
11/14/2006	US7135466 used in the treatment of diseases mediated by the autophosphorylation of a PDGF receptor, specifically, compounds which can inhibit neointima formation hypertrophy.
11/14/2006	US7135132 Photochromic fluorescent polymer and preparation method thereof
11/14/2006	CA2342271C Gem substituted hydroxamic acids
11/14/2006	CA2274669C 1,5-benzodiazepine derivatives
11/14/2006	CA2244363C Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains
11/14/2006	CA2214072C Benzo [b] thiophene compounds, intermediates, processes, compositions, and methods
11/14/2006	CA2128955C Tricyclic benzazepine vasopressin antagonists
11/09/2006	WO2006119400A2 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-trianzin-6-ones, and their use as fungicides
11/09/2006	WO2006117552A1 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity
11/09/2006	WO2006117523A1 Quinazoline derivatives as egf and/or erbb2 tyrosine kinase inhibitors
11/09/2006	WO2006117368A1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives the treatment of infertility
11/09/2006	WO2006117305A1 (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-ht receptor
11/09/2006	WO2006117183A1 3 -m0n0- and 3 , 5-disubstituted piperidine derivatives as renin inhibitors
11/09/2006	WO2005120503A3 N-aryl piperidine compounds for inhibiting hiv infection
11/09/2006	WO2005079802A8 Bipyridyl amides as modulators of metabotropic glutamate receptor-5
11/09/2006	US20060252813 Apparatus for curing a composite laminate
11/09/2006	US20060252799 Benzo (F) insoindol derivatives and their use as EP4 receptor ligands
11/09/2006	US20060252798 Metal ion chelators and therapeutic use thereof
11/09/2006	US20060252797 Receptor regulator
11/09/2006	US20060252795 Chemokine receptor binding heterocyclic compounds
11/09/2006	US20060252793 Useful as adjuvants to chemotherapy or radiation therapy to treat cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2); 2-[4-(3,4-dichloro-phenoxy)-phenyl]-1H-imidazo[4,5-b]pyridine-5-carboxylic acid amide
11/09/2006	US20060252778 Compounds for the treatment of inflammatory disorders
11/09/2006	US20060252768 2,3,6-Trisubstituted-4-pyrimidone derivatives
11/09/2006	US20060252767 Piperazine derivatives and their use as therapeutic agents
11/09/2006	US20060252766 Methods using a combination of 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia
11/09/2006	US20060252764 HIV inhibiting pyrimidines derivatives
11/09/2006	US20060252752 Octahydrocyclopenta[b]pyrrole-sulfonamide-2-carboxylic acid derivatives; reduced side effects
11/09/2006	US20060252751 specific compound N-(2-{[(3R)-1-(4-hydroxy-4-pyrimidin-4-ylcyclohexyl)pyrrolidin-3-yl]amino}-2-oxoethyl)-3-(trifluoromethyl)benzamide; multiple sclerosis; CCR2 and/or CCR5 antagonists
11/09/2006	US20060252747 Substitituted 1-piperidin-3-yl-piperidin 4-yl-piperazine derivatives and their use as neurokinin auantagonists
11/09/2006	US20060252742 prostaglandin receptor agonists; for treating various ocular hypertensive conditions such as post-surgical and post-laser trabeculectomy ocular hypertensive episodes, glaucoma, and as presurgical adjuncts
11/09/2006	US20060252647 Herbicides; broad active spectrum; on soil and above ground plant parts use
11/09/2006	CA2607227A1 (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-ht receptor
11/09/2006	CA2606683A1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
11/09/2006	CA2606538A1 3 -m0n0- and 3 , 5-disubstituted piperidine derivatives as renin inhibitors
11/09/2006	CA2606338A1 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity
11/08/2006	EP1719768A1 Novel benzothiazepine and benzothiepine compounds
11/08/2006	EP1719763A1 Novel pyridine derivative and pyrimidine derivative (2)
11/08/2006	EP1719762A1 Novel pyridine derivative and pyrimidine derivative (1)
11/08/2006	EP1718638A1 Novel compounds
11/08/2006	EP1718632A1 Pyrimidine derivatives as orexin receptor antagonists
11/08/2006	EP1718617A2 3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators
11/08/2006	EP1718616A2 Isoquinoline derivatives
11/08/2006	EP1718615A1 Novel quinoline-carbaxamides as jack3 kinase modulators

1 ... 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 ... 523